Here's What Key Metrics Tell Us About Gen Digital (GEN) Q4 Earnings
https://www.zacks.com/stock/news/2271816/here-s-what-key-metrics-tell-us-about-gen-digital-gen-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2271816
May 09, 2024 - The headline numbers for Gen Digital (GEN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
CarGurus (CARG) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271813/cargurus-carg-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271813
May 09, 2024 - Although the revenue and EPS for CarGurus (CARG) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
0
Compared to Estimates, AMN Healthcare (AMN) Q1 Earnings: A Look at Key Metrics
https://www.zacks.com/stock/news/2271815/compared-to-estimates-amn-healthcare-amn-q1-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2271815
May 09, 2024 - The headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
JFrog (FROG) Reports Q1 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2271817/jfrog-frog-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2271817
May 09, 2024 - The headline numbers for JFrog (FROG) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Here's What Key Metrics Tell Us About Insulet (PODD) Q1 Earnings
https://www.zacks.com/stock/news/2271783/here-s-what-key-metrics-tell-us-about-insulet-podd-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2271783
May 09, 2024 - While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Cambium (CMBM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271782/cambium-cmbm-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271782
May 09, 2024 - While the top- and bottom-line numbers for Cambium (CMBM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Akamai Technologies (AKAM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
https://www.zacks.com/stock/news/2271786/akamai-technologies-akam-q1-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271786
May 09, 2024 - The headline numbers for Akamai Technologies (AKAM) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Here's What Key Metrics Tell Us About Cedar Fair (FUN) Q1 Earnings
https://www.zacks.com/stock/news/2271751/here-s-what-key-metrics-tell-us-about-cedar-fair-fun-q1-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2271751
May 09, 2024 - The headline numbers for Cedar Fair (FUN) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Royalty Pharma (RPRX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2271664/royalty-pharma-rprx-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2271664
May 09, 2024 - The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Playtika (PLTK) Reports Q1 Earnings: What Key Metrics Have to Say
https://www.zacks.com/stock/news/2271547/playtika-pltk-reports-q1-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2271547
May 09, 2024 - The headline numbers for Playtika (PLTK) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0